Evidence that prolactin does not affect the induction of sexual behaviour by oestradiol and progesterone in ovariectomized rats

1983 ◽  
Vol 99 (2) ◽  
pp. 181-187 ◽  
Author(s):  
P. Södersten ◽  
S. Hansen ◽  
P. Eneroth

Injection of 2·5 mg of the dopamine receptor antagonist domperidone raised serum prolactin concentrations within 3 h and high prolactin levels were maintained for 12 h in ovariectomized rats pretreated with 2 μg oestradiol benzoate (OB). This dose of domperidone stimulated the display of sexual behaviour in ovariectomized OB-treated rats within 3 h of administration. The behavioural effect of domperidone, but not its effect on serum prolactin concentrations, was blocked by adrenalectomy. Daily treatment with domperidone had no inhibitory effect on the subsequent induction of sexual behaviour by OB and progesterone in ovariectomized rats. A slight facilitation of the behaviour was noticed in OB-treated rats given daily domperidone injections, but this effect was cancelled by adrenalectomy. The results suggest that an acute increase in serum prolactin levels has no effect on the induction of sexual behaviour by OB in itself, but can stimulate the secretion of an adrenal product, perhaps progesterone, which facilitates the behaviour. Similarly, constant high levels of prolactin by themselves have no effect on the subsequent induction of sexual behaviour by OB and progesterone.

1987 ◽  
Vol 113 (3) ◽  
pp. 423-427 ◽  
Author(s):  
G. Forsberg ◽  
P. Eneroth ◽  
P. Södersten

ABSTRACT During lactation the display of sexual receptivity in response to treatment with oestradiol benzoate (OB; 2 or 10 μg) and progesterone (0·5 mg) was inhibited, but the behaviour could be activated by i.p. (5 mg) or intracerebroventricular (i.c.v.; 100 μg) but not intrathecal (i.t.; 100 or 500 μg) injections of the opioid peptide receptor antagonist naloxone. The behaviour was also inhibited in ovariectomized rats in which serum progesterone and prolactin levels had been raised by treatment with progesterone implants and the dopamine receptor antagonist domperidone, and the uterine cervix had been stimulated. Intraperitoneal injections of naloxone (1 mg) reactivated the behaviour of cervically stimulated rats. The concentration of β-endorphin-like immunoreactivity in the serum of lactating rats (42·8± 9·2 pmol/l) was not raised above that of ovariectomized rats (35·8 ± 8·4 pmol/l) nor was the concentration of β-endorphin-like immunoreactivity altered in the pituitary gland (22·5 ± 2·5 pmol/l), midbrain central grey (6·3 ± 2·2 pmol/l) or hypothalamus (5·6± 2·6 pmol/l) of lactating rats in comparison with ovariectomized rats (24·8 ± 4·4, 4·0 ± 2·0 and 4·7 ± 1·4 pmol/l respectively). Adrenalectomy facilitated the display of sexual behaviour in lactating rats treated with OB plus progesterone and caused a slight increase in serum β-endorphin-like immunoreactivity (30·5± 2·7 pmol/l) compared with that in non-adrenalectomized lactating rats (26·1 ± 2·1 pmol/l). It is suggested that an opioid peptide, but probably not β-endorphin, inhibits sexual behaviour during lactation and after cervical stimulation. J. Endocr. (1987) 113, 423–427


1983 ◽  
Vol 99 (2) ◽  
pp. 189-197 ◽  
Author(s):  
P. Södersten ◽  
S. Hansen ◽  
P. Eneroth

Treatment with oestradiol benzoate (OB; 2–250 μg) and progesterone (0·5–25 mg) failed to induce sexual behaviour in lactating rats 6 days after parturition. Removal of pups permitted the induction of sexual behaviour by OB and progesterone and the inhibitory effect of the presence of pups was proportional to the number present. Ovariectomy of lactating rats or reduction of serum prolactin levels in intact lactating rats by daily treatment with the dopamine receptor agonist bromocriptine (0·5 mg/day) permitted the induction of sexual behaviour despite the presence of suckling pups. Removal of pups from lactating rats and subsequent maintenance of high prolactin levels by daily treatment with the dopamine receptor antagonist domperidone (2·5 mg/day) maintained the state of refractoriness to the behavioural effects of OB and progesterone provided that the ovaries remained in situ. Inhibition of sexual behaviour in lactating rats could be maintained after ovariectomy by implantation of progesterone-filled, but not androgen-filled implants at the time of ovariectomy. Removal of the pups or reduction of prolactin levels by bromocriptine treatment permitted the induction of sexual behaviour by OB in ovariectomized progesterone-implanted lactating rats. Inhibition of the behaviour in ovariectomized progesterone-implanted lactating rats could be maintained after pup removal by daily domperidone treatment. Continuously raised serum progesterone or prolactin levels have no effect on the induction of sexual behaviour in female rats but the present data suggest that during lactation progesterone and prolactin act in synergy to inhibit the behaviour.


1979 ◽  
Vol 80 (3) ◽  
pp. 389-395 ◽  
Author(s):  
P. SÖDERSTEN ◽  
S. HANSEN

The ability of cyclic female rats to show sexual receptivity 24 h after an injection of 2 μg oestradiol benzoate (OB) was lost 24 h after ovariectomy. Exposure of cyclic rats to anti-oestrogen (nitromophene monocitrate) implants 24 h before ovariectomy and OB treatment prevented the latter from inducing sexual receptivity within 24 h of administration. Treatment of ovariectomized rats with constant release implants filled with an oil solution of 15 μg oestradiol/ml had no behavioural effect in itself, but prepared the rats to show lordosis 24 h after administration of OB. Progesterone treatment (4 mg) induced sexual behaviour in cyclic rats on days other than that of the oestrous cycle when the rats are normally receptive. Evidence is presented that a lower level of oestradiol stimulation than that present during pro-oestrus was needed for the induction of sexual receptivity in ovariectomized rats. It is suggested that the low basal level of oestradiol which was present throughout the oestrous cycle was necessary for the induction of sexual receptivity and that an increase in oestradiol stimulation served to increase the behavioural sensitivity to progesterone.


2014 ◽  
Vol 28 (S1) ◽  
Author(s):  
Julie Meade ◽  
R Free ◽  
Nicole Miller ◽  
Amy Moritz ◽  
Jennie Conroy ◽  
...  

Luminescence ◽  
2015 ◽  
Vol 31 (1) ◽  
pp. 63-66 ◽  
Author(s):  
Mohamed Hefnawy ◽  
Mostafa Mohamed ◽  
Mohamed Abunassif ◽  
Amer Alanazi ◽  
Abdulrahman Al-Majed ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document